UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Clinical trials for UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for rare, Hard-to-Treat bone cancer
Disease control OngoingThis study tested an oral drug called vismodegib in patients with advanced chondrosarcoma, a rare type of bone cancer that has spread and is difficult to treat. The main goal was to see if the drug could stop the cancer from growing for at least six months. Researchers also track…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug duo targets rare, Tough-to-Treat bone cancer
Disease control OngoingThis study is testing whether a combination of two drugs, belinostat and either guadecitabine or ASTX727, can help control advanced chondrosarcoma, a rare type of bone cancer that cannot be removed by surgery or has spread. The goal is to see if this treatment can shrink tumors o…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Immune system boost tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a drug called atezolizumab can help control advanced forms of two rare cancers: chondrosarcoma (bone cancer) and clear cell sarcoma (soft tissue cancer). The drug works by helping the patient's own immune system recognize and attack the cancer cells.…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC